In vitro interleukin-13 production by peripheral blood in patients with newly diagnosed insulin-dependent diabetes mellitus and their first degree relatives

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 321-325

  Kretowski A ^a   Mysliwiec J ^b   Kinalska, I ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; INTERLEUKIN 13;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-13; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; PHYTOHEMAGGLUTININS; PREDIABETIC STATE; RECOMBINANT PROTEINS;

EID: 0034071169     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00693.x     Document Type: Article

References (28)

1. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet B-cell destruction and insulin dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-49.
2. Szelachowska M, Krȩtowski A, Kinalska I. Increased in vitro IL-12 production by peripheral blood in high risk IDDM first degree relatives. Horm Metab Res 1997;29:168-71.
3. Rapoport MJ, Mor A, Vardi P et al. Decreased secretion of Th2 cytokines precedes upregulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells form patients with IDDM. J Autoimmun 1998;11:635-42.
4. Zurawski G, de Vries JE. Interleukin-13 and interleukin-4-like cytokine that acts on monocytes and B-cells, but not on T cells. Immunol Today 1994;15:19-26.
5. Lai YH, Mosmann TR. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. J Immunol 1999;162:78-87.
6. Graber P, Gretener D, Herren S et al. The distribution of IL-13 receptor alpha 1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. Eur J Immunol 1998;28:4286-98.
7. Ohta TM, Kasama T, Hanyuuda M et al. Interleukin-13 down regulates the expression of neutrophil derived macrophage inflammatory protein-1 alpha. Inflamm Res 1998;47:361-8.
8. McKenzie ANJ, Culpepper JA, De Waal Malefyt R. Interleukin-13 induces IL-4-independent IgG4 and IgE synthesis and CD23 expression on human B cells. Proc Natl Acad Sci USA 1993;90:3730-4.
9. McKenzie GJ, Emson CL, Bell SE et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998;9:423-32.
10. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-γ. J Immunol 1998;162:51-9.
11. Kucharzik T, Lugering N, Weigelt H, Adolf M, Domschke W, Stoll R. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol 1996;104:483-90.
12. Tokano Y, Morimoto S, Kaneko H et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999;116:169-73.
13. Isomaki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997;29:499-507.
14. McHugh S, Deighton J, Rifkin I, Ewan P. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol 1996;26:1260-5.
15. Bach JF, Koutozov S, Endert PM. Are the unique autoantigens triggering autoimmune diseases? Immunol Rev 1998;164:139-55.
16. Bingley P, Bonifacio E, Wiliams AJK, Genovese S, Botazzo GF, Gale EAM. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 1997;46:1701-10.
17. Bunce M, O'Neill CM, Barnardo MC. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
18. Wassserfal C, Wilson B, Kent S et al. Increased serum interleukin-4 in IDDM. Evidence for inheritance in multiplex families of a trait associated with protection from disease. In: Abstracts of The Congress of ADA, Chicago 1998:A217.
19. Kretowski A, Szelachowska M, Pietruczuk M, Kinalska I. CD23 antigen expression on B lymphocytes and soluble CD23 levels in peripheral blood of high risk type 1 diabetes subjects. Scand J Immunol 1999;49:78-81.
20. Rogan DF, Cousins DJ, Saynov DZ. Intergenic transcription occurs through the human IL-4/IL-13 gene cluster. Bichem Biophys Res Com 1999;255:556-61.
21. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie ANJ. Simultaneous disruption of IL-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999;189:1565-72.
22. Mayer A, Rharbaoui F, Thivolet C, Orgiazzi J, Madec AM. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 diabetes mellitus. J Clin Metab 1999;84:2419-24.
23. Dubois-La Forgue D, Carel JC, Bougneres PF, Guillet JG, Boitard C. T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes. J Clin Immunol 1999;19:127-34.
24. Li Y, Simons FER, HayGlass KT. Environmental antigen induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4, and are inhibited by endogenous INF-gamma synthesis. J Immunol 1998;161:7007-14.
25. Schloot NC, Roep BO, Wegmann D et al. Altered immune response to insulin in newly diagnosed compared to insulin treated diabetic patients and healthy control subjects. Diabetologia 1997;40:564-72.
26. Zaccone P, Phillips J, Conget I et al. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 1999;48:1522-8.
27. Lentsch AB, Czermak BJ, Jordan JA, Ward PA. Regulation of acute lung inflammatory injury by endogenous IL-13. J Immunol 1999;162:1071-6.
28. Roberge FG, de Smet MD, Benichou J, Kriete MF, Raber J, Hakimi J. Treatment of uveitis with recombinant human interleukin-13. Br J Ophthalm 1998;82:1195-8.